Estimating Steatotic Liver Disease Prevalence Among US Veterans
Steatotic liver disease (SLD) is the most common cause of chronic liver disease in the United States.1 Updated SLD nomenclature acknowledge the dual pathology of SLD—metabolic and alcohol—and categorizes SLD spectrum ranging from predominantly metabolic dysfunction–associated steatotic liver disease (MASLD) to dual effects of both metabolic and alcohol (metabolic-associated alcohol-related liver disease (MetALD)) to predominantly alcohol-driven (alcohol-associated liver disease (ALD)) subsets.2 Existing US studies report that among adults with SLD, 86%–92% were of MASLD subtypes, 6%–7% MetALD, and 2%–3% ALD.
Authors
- Robert J. Wong (ORCID: https://orcid.org/0000-0002-8923-2806)
- Mai Sedki (ORCID: https://orcid.org/0000-0003-4243-8548)
- Ramsey Cheung (ORCID: https://orcid.org/0000-0002-0211-7013)
- Wei Zhang (ORCID: https://orcid.org/0000-0003-3113-9577)
- Zeyuan Yang (ORCID: https://orcid.org/0000-0003-0559-6483)
- Ashwani Kumar Singal (ORCID: https://orcid.org/0000-0003-1207-3998)
Institutions
- Harvard University (US)
- VA Palo Alto Health Care System (US)
- Massachusetts General Hospital (US)
- Jewish Hospital (US)
- Louisville VA Medical Center (US)
- University of Louisville Hospital (US)
- Stanford University (US)
Publication Details
- Journal
- Gastro Hep Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.gastha.2025.100804
- Citations
- 1
- Primary Topic
- Alcohol Consumption and Health Effects
- Type
- article
- Field-Weighted Citation Impact
- 1.47